Skip to main content

Table 1 Demographic, clinical and laboratory data of the patients

From: Elevated serum triglycerides is the strongest single indicator for the presence of metabolic syndrome in patients with type 2 diabetes

Variable MS according to NCEP-ATP III criteria MS according to IDF criteria
With MS (n = 364) Without MS (n = 136) p value With MS (n = 419) Without MS (n = 81) p value
Age (years)* 65.9 ± 10.0 62.0 ± 12.9 0.002 65.6 ± 10.2 61.6 ± 13.6 0.010
Diabetes duration (years) 12.7 ± 8.4 11.5 ± 8.5 0.166 12.5 ± 8.3 11.7 ± 8.9 0.389
BMI (kg/m 2 ) 30.0 ± 5.2 26.7 ± 4.3 <0.001 29.9 ± 5.0 25.9 ± 4.8 <0.001
Waist (cm) males 108 ± 11 98 ± 9 <0.001 107 ± 10 95 ± 11 <0.001
Waist (cm) females 105 ± 9 89 ± 17 <0.001 104 ± 10 89 ± 20 <0.001
Serum HDL (mg/d) males 42 ± 10 51 ± 11 <0.001 44 ± 11 51 ± 12 <0.001
Serum HDL (mg/dl) females 49 ± 10 61 ± 10 <0.001 50 ± 11 61 ± 10 <0.001
Serum triglycerides (mg/dl) 172 ± 91 106 ± 50 <0.001 164 ± 90 111 ± 57 <0.001
SBP (mmHg) 134 ± 19 126 ± 14 <0.001 134 ± 19 123 ± 11 <0.001
DBP (mmHg) 79 ± 11 75 ± 8 <0.001 79 ± 11 74 ± 6 <0.001
Glycosylated hemoglobin (%) 7.1 ± 1.3 7.0 ± 1.3 0.137 7.1 ± 1.3 7.0 ± 1.3 0.416